IP Library Granted Patent US 11,744,999
Granted Patent B2
US 11,744,999 · App. 17/164,580 · Granted Sep 5, 2023

Devices and methods for treating the skin

Inventors: Roger Ignon (Redondo Beach, CA); Ed F. Nicolas (Signal Hill, CA)
Assignee: Hydra Facial LLC
A61M35/003A45D34/04A45D34/041A61B17/3205A61B17/54A61B17/545A61M35/006A61M37/00A45D2034/005A61B2017/00747A61B2017/00761A61B2017/320004A61B2217/005A61M2210/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,744,999
App. No.
17/164,580
Granted
Sep 5, 2023
Kind
B2
Abstract

According to some embodiments, a skin treatment assembly comprises a handpiece comprising a distal end, the handpiece comprising a recess or cavity configured to receive a cartridge or other fluid container, a tip configured to be positioned along the distal end of the handpiece, the tip being configured to contact a skin surface of a subject during use, and at least one rollerball configured to extend to or near the tip, wherein the rollerball is configured to be in fluid communication with an interior of a cartridge or other fluid container secured to the handpiece, wherein the at least one rollerball is configured to contact the skin surface of the subject during use and to facilitate the delivery of fluids to said skin surface as the rollerball is moved relative to said skin surface.

Claims (36)

1. A skin treatment system comprising:

a handpiece assembly comprising a longitudinal axis, an interior portion, a proximal end and a distal end, the proximal end extending to a proximal-most location along the longitudinal axis, the handpiece assembly comprising a suction port extending along an exterior of the handpiece assembly, wherein the handpiece assembly comprises a peripheral lip along the distal end of the handpiece assembly;

a cartridge configured to releasably secure to the handpiece assembly, the cartridge comprising an interior chamber configured to contain a treatment fluid;

a rollerball positioned along a distal end of the cartridge, wherein the rollerball is configured to be in fluid communication with the interior of the cartridge; and

a vacuum source;

wherein the cartridge is configured to be positioned through the interior portion of the handpiece assembly to removably secure the cartridge to the handpiece assembly, wherein the rollerball extends distally past the peripheral lip of the handpiece assembly when the cartridge is secured to the handpiece assembly, and wherein, when the cartridge is secured to the handpiece assembly, a proximal portion of the cartridge is proximal of the proximal-most location of the handpiece assembly and the suction port, and the cartridge and the handpiece assembly form an exterior surface that can be grasped and manipulated during use;

wherein the rollerball is configured to be surrounded by the peripheral lip of the handpiece assembly when the cartridge is secured to the handpiece assembly;

wherein the rollerball is configured to rotate to facilitate a transfer of the treatment fluid from the interior chamber of the cartridge to the rollerball; and

wherein the suction port is configured to be placed in fluid communication with the vacuum source to generate a suction along the distal end of the handpiece assembly when the vacuum source is activated; and

wherein, during use, the handpiece assembly is configured such that the suction along the distal end of the handpiece assembly is maintained as the cartridge is slidably separated relative to the handpiece assembly.

2. The system of claim 1 , wherein the cartridge is configured to be separated from the handpiece assembly and provided to a subject being treated to permit the subject to apply the treatment fluid to skin tissue.

3. The system of claim 1 , wherein the cartridge is disposable.

4. The system of claim 1 , wherein the cartridge is reusable.

5. The system of claim 1 , wherein the cartridge is configured to be selectively opened to access to the interior chamber.

6. The system of claim 1 , wherein the cartridge is configured to remain sealed at all times.

7. The system of claim 1 , wherein the cartridge is configured to contain an acid.

8. The system of claim 1 , further comprising a cap configured to be positioned along the distal end of the cartridge between uses of the cartridge.

9. The system of claim 1 , wherein the cartridge is configured to help maintain the treatment fluid within the interior chamber immediately adjacent the rollerball.

10. The system of claim 9 , wherein one or more vanes are positioned adjacent the rollerball to help maintain the treatment fluid immediately adjacent the rollerball.

11. The system of claim 9 , wherein a wicking or other porous member is positioned adjacent the rollerball to help maintain the treatment fluid immediately adjacent the rollerball.

12. The system of claim 1 , wherein the peripheral lip is configured to contact a subject's skin tissue and form a seal along said skin tissue during use.

13. A skin treatment system comprising:

a handpiece assembly comprising a suction port extending along an exterior of the handpiece assembly, the handpiece assembly comprising a longitudinal axis, a proximal end, an interior portion and a peripheral lip along a distal end, the proximal end extending to a proximal-most location along the longitudinal axis;

a cartridge configured to releasably secure to the handpiece assembly, the cartridge comprising an interior chamber configured to contain a treatment fluid, wherein, when the cartridge is secured to the handpiece assembly, a proximal portion of the cartridge is proximal of the proximal end of the handpiece assembly, and the cartridge and the handpiece assembly form an exterior surface that can be grasped and manipulated during use; and

a rollerball positioned along a distal end of the cartridge, wherein the rollerball is configured to be in fluid communication with the interior of the cartridge;

wherein the rollerball extends distally past the peripheral lip of the handpiece assembly when the cartridge is removably secured to the handpiece assembly, wherein the cartridge is configured to be positioned through the interior portion of the handpiece assembly to removably secure the cartridge to the handpiece assembly;

wherein a proximal portion of the cartridge is proximal of the proximal-most location of the handpiece assembly and the suction port, and wherein the cartridge and the handpiece assembly form an exterior surface that can be grasped and manipulated during use;

wherein the rollerball is configured to be surrounded by the peripheral lip of the handpiece assembly when the cartridge is secured to the handpiece assembly; and

wherein the suction port is configured to be placed in fluid communication with the vacuum source.

14. The system of claim 13 , wherein the cartridge is configured to be separated from the handpiece assembly and provided to a subject being treated to permit the subject to apply the treatment fluid to skin tissue.

15. The system of claim 13 , wherein the cartridge is disposable or reusable.

16. The system of claim 13 , further comprising a cap configured to be positioned along the distal end of the cartridge between uses of the cartridge.

17. The system of claim 13 , wherein the cartridge is configured to help maintain the treatment fluid within the interior chamber immediately adjacent the rollerball.

18. The system of claim 17 , wherein one or more vanes are positioned adjacent the rollerball to help maintain the treatment fluid immediately adjacent the rollerball.

19. The system of claim 17 , wherein a wicking or other porous member is positioned adjacent the rollerball to help maintain the treatment fluid immediately adjacent the rollerball.

20. The system of claim 13 , wherein the peripheral lip is configured to contact a subject's skin tissue and form a seal along said skin tissue during use.

Assignments (5)
PATENT SECURITY AGREEMENT Recorded May 30, 2025
From: HYDRAFACIAL LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071475/0338 →
RELEASE OF SECURITY INTEREST IN PATENTS AT REEL/FRAME NO. 58526/0897 Recorded Aug 6, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: HYDRAFACIAL LLC (FORMERLY KNOWN AS EDGE SYSTEMS LLC)
Reel/Frame 068378/0060 →
CHANGE OF NAME Recorded Aug 16, 2022
From: EDGE SYSTEMS LLC
To: HYDRAFACIAL LLC
Reel/Frame 061201/0733 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2022
From: IGNON, ROGER; NICOLAS, ED F.
To: EDGE SYSTEMS LLC
Reel/Frame 060812/0661 →
SECURITY INTEREST Recorded Jan 3, 2022
From: EDGE SYSTEMS LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 058526/0897 →
Continuity (6)
Continuation 16040397 · Jul 19, 2018
Continuation 15354754 · Nov 17, 2016
Continuation 14998375 · Dec 23, 2015
Provisional Application 62235479 · Sep 30, 2015
Provisional Application 62096493 · Dec 23, 2014
Related Publication 20210154453A1 · May 27, 2021
Cited By (10)
US 1,065,551 US 1,084,369 US 1,112,778 US 1,116,120 US 1,141,134 US 12,186,513 US 12,295,618 US 12,478,771 US 12,544,051 US 12,653,352